These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35294425)

  • 1. Clinical Indication of Aspirin Associated With Reduced Risk of Liver Cancer in Chronic Hepatitis B: A Nationwide Cohort Study.
    Yun B; Ahn SH; Yoon JH; Kim BK
    Am J Gastroenterol; 2022 May; 117(5):758-768. PubMed ID: 35294425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
    Lee TY; Hsu YC; Tseng HC; Yu SH; Lin JT; Wu MS; Wu CY
    JAMA Intern Med; 2019 May; 179(5):633-640. PubMed ID: 30882847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis.
    Hsiang JC; Wong GL; Tse YK; Wong VW; Yip TC; Chan HL
    J Hepatol; 2015 Nov; 63(5):1190-7. PubMed ID: 26208777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between daily aspirin therapy and risk of hepatocellular carcinoma according to metabolic risk factor burden in non-cirrhotic patients with chronic hepatitis B.
    Lee CH; Lee YB; Moon H; Chung JW; Cho EJ; Lee JH; Yu SJ; Kim YJ; Lee J; Yoon JH
    Aliment Pharmacol Ther; 2023 Oct; 58(7):704-714. PubMed ID: 37461332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Daily Aspirin Therapy With Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis C Virus Infection.
    Lee TY; Hsu YC; Tseng HC; Lin JT; Wu MS; Wu CY
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2784-2792.e7. PubMed ID: 32360983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B.
    Lee J; Yoo SH; Sohn W; Kim HW; Choi YS; Won JH; Heo JY; Park SJ; Park YM
    Clin Mol Hepatol; 2016 Sep; 22(3):339-349. PubMed ID: 27729627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of aspirin and statin use with the risk of liver cancer in chronic hepatitis B: A nationwide population-based study.
    Choi WM; Kim HJ; Jo AJ; Choi SH; Han S; Ko MJ; Lim YS
    Liver Int; 2021 Nov; 41(11):2777-2785. PubMed ID: 34242482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
    Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis.
    Jang H; Lee YB; Moon H; Chung JW; Nam JY; Cho EJ; Lee JH; Yu SJ; Kim YJ; Lee J; Yoon JH
    Hepatology; 2022 Aug; 76(2):492-501. PubMed ID: 35100447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
    Goh MJ; Sinn DH; Kim S; Woo SY; Cho H; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Hepatology; 2020 Jun; 71(6):2023-2032. PubMed ID: 31556128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B Virus Combo Mutations Improve the Prediction and Active Prophylaxis of Hepatocellular Carcinoma: A Clinic-Based Cohort Study.
    Yin J; Wang J; Pu R; Xin H; Li Z; Han X; Ding Y; Du Y; Liu W; Deng Y; Ji X; Wu M; Yu M; Zhang H; Wang H; Thompson TC; Ni W; Cao G
    Cancer Prev Res (Phila); 2015 Oct; 8(10):978-88. PubMed ID: 26290395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study.
    Liao YH; Hsu RJ; Wang TH; Wu CT; Huang SY; Hsu CY; Su YC; Hsu WL; Liu DW
    BMC Gastroenterol; 2020 Jan; 20(1):6. PubMed ID: 31918672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection.
    Hosaka T; Suzuki F; Kobayashi M; Seko Y; Kawamura Y; Sezaki H; Akuta N; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Kumada H
    Hepatology; 2013 Jul; 58(1):98-107. PubMed ID: 23213040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study.
    Wu CY; Lin JT; Ho HJ; Su CW; Lee TY; Wang SY; Wu C; Wu JC
    Gastroenterology; 2014 Jul; 147(1):143-151.e5. PubMed ID: 24704525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin use and the risk of hepatocellular carcinoma among patients with chronic hepatitis B: an emulated target trial using longitudinal nationwide population cohort data.
    Sinn DH; Kang D; Park Y; Kim H; Hong YS; Cho J; Gwak GY
    BMC Gastroenterol; 2023 Oct; 23(1):366. PubMed ID: 37880589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population.
    Gordon SC; Lamerato LE; Rupp LB; Li J; Holmberg SD; Moorman AC; Spradling PR; Teshale EH; Vijayadeva V; Boscarino JA; Henkle EM; Oja-Tebbe N; Lu M;
    Clin Gastroenterol Hepatol; 2014 May; 12(5):885-93. PubMed ID: 24107395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.
    Cho HJ; Kim B; Lee JD; Kang DR; Kim JK; Lee JH; Shin SJ; Lee KM; Yoo BM; Lee KJ; Kim SS; Cheong JY; Cho SW
    Am J Gastroenterol; 2017 Mar; 112(3):460-470. PubMed ID: 27779194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease.
    Cho JY; Paik YH; Sohn W; Cho HC; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Gut; 2014 Dec; 63(12):1943-50. PubMed ID: 24615378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis Comparison Between Chronic Hepatitis B Patients Receiving a Finite Course of Tenofovir and Entecavir Treatment: A Nationwide Cohort Study in Taiwan.
    Lin CL; Lin YL; Liang KH; Chen LW; Chien CH; Hu CC; Huang TS; Shyu YC; Yeh CT; Chien RN
    Clin Ther; 2022 Mar; 44(3):403-417.e6. PubMed ID: 35469645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A comparative cross-sectional study of the development of hepatocellular carcinoma in patients with liver cirrhosis caused by hepatitis B virus, alcohol, or combination of hepatitis b virus and alcohol].
    Chung NS; Kwon OS; Park CH; Kim YN; Cho GH; Lee JJ; Kim GH; Kim HO; Ko KI; Yu SK; Kwon KA; Kim YS; Choi DJ; Kim JH
    Korean J Gastroenterol; 2007 Jun; 49(6):369-75. PubMed ID: 17641555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.